Table 9.
Sub-populations comparison in Day 21 expanded pNK versus Day 21 expanded PB NK.
| NK sub-populations | Combo (12 U) |
PB (9 U) |
p Value | ||
|---|---|---|---|---|---|
| Mean (%) | SD | Mean (%) | SD | ||
| CD16− | 35.98 | 18.18 | 28.39 | 7.78 | NS |
| CD16+ | 63.80 | 18.32 | 71.50 | 7.78 | NS |
| KIR3DL1+ | 17.92 | 13.44 | 8.83 | 6.44 | NS |
| KIR2DL2/L3+ | 21.10 | 10.48 | 37.40 | 17.82 | * |
| NKG2D+ | 89.28 | 12.88 | 73.27 | 20.06 | NS |
| NKp46+ | 88.74 | 5.34 | 64.97 | 17.26 | ** |
| CD226+ | 18.79 | 12.14 | 4.80 | 1.72 | NS |
| NKp44+ | 64.13 | 16.65 | 16.00 | 3.82 | ** |
| NKp30+ | 84.53 | 12.40 | 55.77 | 1.96 | * |
| 2B4+ | 0.89 | 0.99 | 2.16 | 1.76 | NS |
| CD94+ | 74.82 | 12.45 | 71.76 | 20.35 | NS |
*p < 0.05; **p < 0.01; ***p < 0.001.